US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Atossa Genetics

0.7311

+0.02693.82%

Post-market: 0.7165-0.0146-2.00%19:55 EST

Volume:945.80K

Turnover:678.90K

Market Cap:94.44M

PE:-3.11

High:0.7401

Open:0.7100

Low:0.7015

Close:0.7042

52wk High:1.29

52wk Low:0.5526

Shares:129.17M

Float Shares:129.10M

Volume Ratio:0.78

T/O Rate:0.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2348

EPS(LYR):-0.2026

ROE:-48.89%

ROA:-29.87%

PB:1.90

PE(LYR):-3.61

Loading ...

Overview Company News Filings

Atossa Therapeutics - Heather Rees Steps Down as CFO, Assists Transition Until Nov 15 - SEC Filing

THOMSON REUTERS

Atossa Therapeutics Appoints Mark Daniel as Chief Financial Officer to Lead Commercial Readiness

Atossa Therapeutics Granted Israeli Patent for High-Purity Z-Endoxifen Formulations

BRIEF-Atossa Therapeutics Streamlines Evangeline Breast Cancer Clinical Trial To Prioritize For 2026 NDA-Enabling Activities

Atossa Therapeutics - No Change to Patient Safety Data Collection or Data Safety Monitoring Committee Oversight by This Amendment

THOMSON REUTERS

Atossa Therapeutics Streamlines Evangeline Breast Cancer Clinical Trial to Prioritize for 2026 Nda-Enabling Activities

THOMSON REUTERS

Atossa Therapeutics Inc - Focuses on Nda-Enabling Activities for Investigational (Z)-Endoxifen in 2026

THOMSON REUTERS

Atossa Therapeutics Inc - Evangeline Study Patient Total Reduced to 40-65

THOMSON REUTERS

Atossa Therapeutics Inc - Changes Expected to Reduce Study Costs and Accelerate Readouts

THOMSON REUTERS

Atossa Therapeutics Appoints Janet R. Rea as Senior Vice President of R&D to Accelerate (Z)-Endoxifen Toward Regulatory Milestones

Atossa Therapeutics Inc. Releases Updated Corporate Presentation

BRIEF-Atossa Unveils Regulatory Strategy to Fast-Track (Z)-Endoxifen for Breast Cancer Risk Reduction

Atossa Therapeutics Inc. Requests Type C FDA Meeting to Expedite Development of Low-Dose (Z)-Endoxifen for Breast Cancer Risk Reduction; Update Expected by Year-End 2025

Atossa Therapeutics Inc - Requests Type C Meeting With FDA

THOMSON REUTERS

Atossa Therapeutics Inc - Expects Meeting Outcome Update by Year-End 2025

THOMSON REUTERS

Atossa Therapeutics Announces Regulatory Strategy Aimed at Accelerating Development of Low-Dose (Z)-Endoxifen for Breast Cancer Risk Reduction

THOMSON REUTERS

Atossa Therapeutics Announces New Clinical Study Progress and Upcoming Milestones for Breast Cancer Treatment at H.C. Wainwright Conference

Atossa Therapeutics Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Requirement

Atossa Therapeutics Announces Pivotal Phase 2 Study of (Z)-Endoxifen in Metastatic Breast Cancer with PSI as Contract Research Organization

Atossa Therapeutics Selects PSI as Contract Research Organization for Pivotal Dose-Ranging Study of (Z)-Endoxifen in Metastatic Breast Cancer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATOS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ATOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATOS\",,,,,undefined,":{"symbol":"ATOS","market":"US","secType":"STK","nameCN":"Atossa Genetics","latestPrice":0.7311,"timestamp":1766178000000,"preClose":0.7042,"halted":0,"volume":945804,"hourTrading":{"tag":"盘后","latestPrice":0.7165,"preClose":0.7311,"latestTime":"19:55 EST","volume":15403,"amount":10979.2715,"timestamp":1766192145337},"delay":0,"floatShares":129099914,"shares":129171424,"eps":-0.234807,"marketStatus":"Market Closed","change":0.0269,"latestTime":"12-19 16:00:00 EST","open":0.71,"high":0.7401,"low":0.7015,"amount":678899.08537812,"amplitude":0.054814,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.234807,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1352350800000,"exchange":"NASDAQ","adjPreClose":0.7042,"preHourTrading":{"tag":"盘前","latestPrice":0.71,"preClose":0.7042,"latestTime":"09:05 EST","volume":4414,"amount":3112.6084622000003,"timestamp":1766153149896},"postHourTrading":{"tag":"盘后","latestPrice":0.7165,"preClose":0.7311,"latestTime":"19:55 EST","volume":15403,"amount":10979.2715,"timestamp":1766192145337},"volumeRatio":0.7799290100514643,"impliedVol":1.7302,"impliedVolPercentile":0.916},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATOS\",,,,,undefined,":{"symbol":"ATOS","floatShares":129099914,"roa":"-29.87%","roe":"-48.89%","lyrEps":-0.202639,"volumeRatio":0.7799290100514643,"shares":129171424,"dividePrice":0,"high":0.7401,"amplitude":0.054814,"preClose":0.7042,"low":0.7015,"week52Low":0.5526,"pbRate":"1.90","week52High":1.29,"institutionHeld":0,"latestPrice":0.7311,"eps":-0.234807,"divideRate":0,"volume":945804,"delay":0,"ttmEps":-0.234807,"open":0.71,"prevYearClose":0.9441,"prevWeekClose":0.825,"prevMonthClose":0.7775,"prevQuarterClose":0.867,"fiveDayClose":0.825,"twentyDayClose":0.752,"sixtyDayClose":0.8167},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"ATOS","fiscalQuarterEnding":"2025/09","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-08-12","symbol":"ATOS","fiscalQuarterEnding":"2025/06","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-05-13","symbol":"ATOS","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-03-25","symbol":"ATOS","fiscalQuarterEnding":"2024/12","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-11-12","symbol":"ATOS","fiscalQuarterEnding":"2024/09","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATOS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1749099600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATOS","date":"2025-12-19","current":-3.113621,"percent":0.947154,"low":-56.54649,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52671,"high":-2.526526,"avg":-7.666205,"sd":7.08507,"marketCap":90962516},"quantilePoints":[{"date":"2020-12-24","current":-2.664265,"twenty":-1.66859,"median":-0.841705,"eighty":-0.481914,"marketCap":34535966},{"date":"2020-12-31","current":-2.863181,"twenty":-1.683775,"median":-0.841705,"eighty":-0.481914,"marketCap":37114443},{"date":"2021-01-08","current":-5.282209,"twenty":-1.686108,"median":-0.84178,"eighty":-0.481914,"marketCap":68471482},{"date":"2021-01-15","current":-6.885049,"twenty":-1.692773,"median":-0.842439,"eighty":-0.481914,"marketCap":89248543},{"date":"2021-01-22","current":-10.300033,"twenty":-1.703499,"median":-0.845174,"eighty":-0.481914,"marketCap":133515821},{"date":"2021-01-29","current":-12.172766,"twenty":-1.715926,"median":-0.847527,"eighty":-0.481914,"marketCap":157791425},{"date":"2021-02-05","current":-21.478921,"twenty":-1.732601,"median":-0.848569,"eighty":-0.481914,"marketCap":278423949},{"date":"2021-02-12","current":-20.098528,"twenty":-1.745522,"median":-0.852003,"eighty":-0.481914,"marketCap":260530379},{"date":"2021-02-19","current":-17.172094,"twenty":-1.751452,"median":-0.852232,"eighty":-0.481914,"marketCap":222596010},{"date":"2021-02-26","current":-15.01868,"twenty":-1.773381,"median":-0.852232,"eighty":-0.481914,"marketCap":194682041},{"date":"2021-03-05","current":-12.313109,"twenty":-1.783844,"median":-0.852043,"eighty":-0.481618,"marketCap":159610644},{"date":"2021-03-12","current":-16.067779,"twenty":-1.817246,"median":-0.852421,"eighty":-0.481618,"marketCap":208281154},{"date":"2021-03-19","current":-15.349974,"twenty":-1.829769,"median":-0.853652,"eighty":-0.481618,"marketCap":198976498},{"date":"2021-03-26","current":-14.819522,"twenty":-1.836981,"median":-0.855734,"eighty":-0.481914,"marketCap":192100420},{"date":"2021-04-01","current":-14.638806,"twenty":-1.850765,"median":-0.855734,"eighty":-0.481914,"marketCap":260980634},{"date":"2021-04-09","current":-13.689995,"twenty":-1.873373,"median":-0.858429,"eighty":-0.481618,"marketCap":244065223},{"date":"2021-04-16","current":-11.046877,"twenty":-1.897673,"median":-0.863848,"eighty":-0.481618,"marketCap":196943719},{"date":"2021-04-23","current":-11.995688,"twenty":-1.909665,"median":-0.867984,"eighty":-0.481618,"marketCap":213859131},{"date":"2021-04-30","current":-15.790934,"twenty":-1.922392,"median":-0.868606,"eighty":-0.481618,"marketCap":281520777},{"date":"2021-05-07","current":-18.569597,"twenty":-1.952976,"median":-0.869364,"eighty":-0.481618,"marketCap":331058768},{"date":"2021-05-14","current":-19.023761,"twenty":-1.97085,"median":-0.879213,"eighty":-0.481618,"marketCap":350390667},{"date":"2021-05-21","current":-21.188534,"twenty":-1.984771,"median":-0.8803,"eighty":-0.481618,"marketCap":390262708},{"date":"2021-05-28","current":-21.122935,"twenty":-2.009032,"median":-0.885764,"eighty":-0.481618,"marketCap":389054464},{"date":"2021-06-04","current":-30.30682,"twenty":-2.028564,"median":-0.885764,"eighty":-0.481618,"marketCap":558208580},{"date":"2021-06-11","current":-28.273245,"twenty":-2.039544,"median":-0.885768,"eighty":-0.481618,"marketCap":520753026},{"date":"2021-06-18","current":-35.095559,"twenty":-2.055075,"median":-0.895581,"eighty":-0.481618,"marketCap":646410368},{"date":"2021-06-25","current":-56.54649,"twenty":-2.067664,"median":-0.905057,"eighty":-0.481618,"marketCap":1041506052},{"date":"2021-07-02","current":-35.226758,"twenty":-2.087317,"median":-0.911656,"eighty":-0.481618,"marketCap":648826856},{"date":"2021-07-09","current":-34.898762,"twenty":-2.107728,"median":-0.917115,"eighty":-0.481618,"marketCap":642785637},{"date":"2021-07-16","current":-29.519629,"twenty":-2.115375,"median":-0.922574,"eighty":-0.481618,"marketCap":543709656},{"date":"2021-07-23","current":-27.420456,"twenty":-2.139537,"median":-0.934503,"eighty":-0.481618,"marketCap":505045858},{"date":"2021-07-30","current":-20.525084,"twenty":-2.160122,"median":-0.943574,"eighty":-0.481618,"marketCap":378042910},{"date":"2021-08-06","current":-23.202269,"twenty":-2.173818,"median":-0.944411,"eighty":-0.481618,"marketCap":427352855},{"date":"2021-08-13","current":-18.918779,"twenty":-2.194723,"median":-0.955329,"eighty":-0.481618,"marketCap":407726884},{"date":"2021-08-20","current":-19.153794,"twenty":-2.213427,"median":-0.966247,"eighty":-0.481618,"marketCap":412791814},{"date":"2021-08-27","current":-21.915231,"twenty":-2.238204,"median":-0.971483,"eighty":-0.481618,"marketCap":472304744},{"date":"2021-09-03","current":-22.032739,"twenty":-2.260964,"median":-0.978233,"eighty":-0.482893,"marketCap":474837210},{"date":"2021-09-10","current":-23.325326,"twenty":-2.270037,"median":-0.992208,"eighty":-0.482893,"marketCap":502694326},{"date":"2021-09-17","current":-21.033922,"twenty":-2.288598,"median":-0.993831,"eighty":-0.482893,"marketCap":453311256},{"date":"2021-09-24","current":-19.858842,"twenty":-2.306658,"median":-1.000057,"eighty":-0.482893,"marketCap":427986605},{"date":"2021-10-01","current":-19.095041,"twenty":-2.376607,"median":-1.011331,"eighty":-0.482893,"marketCap":411525582},{"date":"2021-10-08","current":-18.683763,"twenty":-2.40205,"median":-1.018076,"eighty":-0.482983,"marketCap":402661954},{"date":"2021-10-15","current":-16.803636,"twenty":-2.425515,"median":-1.028048,"eighty":-0.488626,"marketCap":362142512},{"date":"2021-10-22","current":-16.333604,"twenty":-2.462678,"median":-1.035775,"eighty":-0.497592,"marketCap":352012651},{"date":"2021-10-29","current":-15.09977,"twenty":-2.503041,"median":-1.055103,"eighty":-0.507425,"marketCap":325421767},{"date":"2021-11-05","current":-16.098588,"twenty":-2.562582,"median":-1.072428,"eighty":-0.531824,"marketCap":346947721},{"date":"2021-11-12","current":-15.569802,"twenty":-2.611254,"median":-1.079106,"eighty":-0.553119,"marketCap":335551628},{"date":"2021-11-19","current":-12.794512,"twenty":-2.659443,"median":-1.085262,"eighty":-0.568693,"marketCap":297566658},{"date":"2021-11-26","current":-12.413399,"twenty":-2.727565,"median":-1.09038,"eighty":-0.575917,"marketCap":288702970},{"date":"2021-12-03","current":-10.507833,"twenty":-2.792997,"median":-1.097263,"eighty":-0.587588,"marketCap":244384532},{"date":"2021-12-10","current":-10.943391,"twenty":-2.856481,"median":-1.099625,"eighty":-0.599728,"marketCap":254514461},{"date":"2021-12-17","current":-10.725612,"twenty":-2.905335,"median":-1.108181,"eighty":-0.610945,"marketCap":249449496},{"date":"2021-12-23","current":-9.800052,"twenty":-2.974256,"median":-1.108562,"eighty":-0.624983,"marketCap":227923398},{"date":"2021-12-31","current":-8.711157,"twenty":-3.128969,"median":-1.114803,"eighty":-0.633499,"marketCap":202598576},{"date":"2022-01-07","current":-8.330044,"twenty":-5.482702,"median":-1.119099,"eighty":-0.644504,"marketCap":193734888},{"date":"2022-01-14","current":-7.948931,"twenty":-7.201712,"median":-1.123862,"eighty":-0.651457,"marketCap":184871200},{"date":"2022-01-21","current":-6.860036,"twenty":-7.611374,"median":-1.135476,"eighty":-0.660331,"marketCap":159546378},{"date":"2022-01-28","current":-6.751147,"twenty":-7.589596,"median":-1.145579,"eighty":-0.668417,"marketCap":157013896},{"date":"2022-02-04","current":-6.805591,"twenty":-7.589596,"median":-1.150539,"eighty":-0.673229,"marketCap":158280137},{"date":"2022-02-11","current":-7.404483,"twenty":-7.738189,"median":-1.157174,"eighty":-0.683463,"marketCap":172208789},{"date":"2022-02-18","current":-6.860036,"twenty":-7.738189,"median":-1.172103,"eighty":-0.688731,"marketCap":159546378},{"date":"2022-02-25","current":-6.805591,"twenty":-7.738189,"median":-1.187337,"eighty":-0.703334,"marketCap":158280137},{"date":"2022-03-04","current":-7.435464,"twenty":-7.956848,"median":-1.20507,"eighty":-0.709225,"marketCap":153215173},{"date":"2022-03-11","current":-7.435464,"twenty":-7.991487,"median":-1.215898,"eighty":-0.717544,"marketCap":153215173},{"date":"2022-03-18","current":-9.586218,"twenty":-8.062425,"median":-1.232652,"eighty":-0.722939,"marketCap":197533611},{"date":"2022-03-25","current":-8.848817,"twenty":-8.340933,"median":-1.245717,"eighty":-0.724233,"marketCap":182338718},{"date":"2022-04-01","current":-7.619814,"twenty":-8.430956,"median":-1.256015,"eighty":-0.732518,"marketCap":157013896},{"date":"2022-04-08","current":-7.066763,"twenty":-8.430956,"median":-1.270862,"eighty":-0.742242,"marketCap":145617726},{"date":"2022-04-14","current":-6.820963,"twenty":-8.430956,"median":-1.279552,"eighty":-0.746236,"marketCap":140552762},{"date":"2022-04-22","current":-6.267912,"twenty":-8.430956,"median":-1.303703,"eighty":-0.748228,"marketCap":129156592},{"date":"2022-04-29","current":-6.206462,"twenty":-8.430956,"median":-1.343511,"eighty":-0.753216,"marketCap":127890351},{"date":"2022-05-06","current":-6.057138,"twenty":-8.430956,"median":-1.407132,"eighty":-0.754543,"marketCap":124813385},{"date":"2022-05-13","current":-5.714714,"twenty":-8.430956,"median":-1.428042,"eighty":-0.756108,"marketCap":124889359},{"date":"2022-05-20","current":-5.558853,"twenty":-8.430956,"median":-1.503333,"eighty":-0.758684,"marketCap":121483171},{"date":"2022-05-27","current":-5.550741,"twenty":-8.430956,"median":-1.561647,"eighty":-0.762567,"marketCap":121305897},{"date":"2022-06-03","current":-5.909975,"twenty":-8.430956,"median":-1.621295,"eighty":-0.76678,"marketCap":129156592},{"date":"2022-06-10","current":-6.547325,"twenty":-8.430956,"median":-1.636347,"eighty":-0.77591,"marketCap":143085244},{"date":"2022-06-17","current":-6.025857,"twenty":-8.430956,"median":-1.644408,"eighty":-0.78054,"marketCap":131689074},{"date":"2022-06-24","current":-6.779089,"twenty":-8.443246,"median":-1.662719,"eighty":-0.783078,"marketCap":148150208},{"date":"2022-07-01","current":-5.852034,"twenty":-8.443246,"median":-1.676651,"eighty":-0.787472,"marketCap":127890351},{"date":"2022-07-08","current":-6.25762,"twenty":-8.443246,"median":-1.684712,"eighty":-0.79295,"marketCap":136754038},{"date":"2022-07-15","current":-5.967916,"twenty":-8.443246,"median":-1.688742,"eighty":-0.79638,"marketCap":130422833},{"date":"2022-07-22","current":-5.69907,"twenty":-8.443246,"median":-1.700833,"eighty":-0.80382,"marketCap":124547474},{"date":"2022-07-29","current":-5.452821,"twenty":-8.443246,"median":-1.708894,"eighty":-0.807837,"marketCap":119165949},{"date":"2022-08-05","current":-5.794093,"twenty":-8.443246,"median":-1.724621,"eighty":-0.811954,"marketCap":126624110},{"date":"2022-08-12","current":-6.364797,"twenty":-8.443246,"median":-1.742956,"eighty":-0.815655,"marketCap":136754038},{"date":"2022-08-19","current":-5.952264,"twenty":-8.443246,"median":-1.751852,"eighty":-0.820778,"marketCap":127890351},{"date":"2022-08-26","current":-5.654651,"twenty":-8.443246,"median":-1.773381,"eighty":-0.82749,"marketCap":121495833},{"date":"2022-09-02","current":-5.379433,"twenty":-8.443246,"median":-1.784444,"eighty":-0.831091,"marketCap":115582487},{"date":"2022-09-09","current":-5.569198,"twenty":-8.443246,"median":-1.817246,"eighty":-0.836558,"marketCap":119659783},{"date":"2022-09-16","current":-5.486102,"twenty":-8.443246,"median":-1.829618,"eighty":-0.841631,"marketCap":117874383},{"date":"2022-09-23","current":-4.857873,"twenty":-8.443246,"median":-1.835652,"eighty":-0.842026,"marketCap":104376253},{"date":"2022-09-30","current":-4.910913,"twenty":-8.443246,"median":-1.853989,"eighty":-0.844965,"marketCap":105515870},{"date":"2022-10-07","current":-4.780081,"twenty":-8.443246,"median":-1.874074,"eighty":-0.847792,"marketCap":102704815},{"date":"2022-10-14","current":-4.773598,"twenty":-8.443246,"median":-1.898518,"eighty":-0.850625,"marketCap":102565529},{"date":"2022-10-21","current":-4.832531,"twenty":-8.443246,"median":-1.910415,"eighty":-0.852421,"marketCap":103831770},{"date":"2022-10-28","current":-5.775464,"twenty":-8.443246,"median":-1.922963,"eighty":-0.857816,"marketCap":124091627},{"date":"2022-11-04","current":-5.043513,"twenty":-8.443246,"median":-1.955555,"eighty":-0.863323,"marketCap":108364913},{"date":"2022-11-11","current":-4.377471,"twenty":-8.443246,"median":-1.971852,"eighty":-0.868357,"marketCap":106376914},{"date":"2022-11-18","current":-4.150807,"twenty":-8.443246,"median":-1.985886,"eighty":-0.868357,"marketCap":100868766},{"date":"2022-11-25","current":-4.272737,"twenty":-8.443246,"median":-2.000113,"eighty":-0.868357,"marketCap":103831770},{"date":"2022-12-02","current":-3.987714,"twenty":-8.443246,"median":-2.029426,"eighty":-0.868357,"marketCap":96905431},{"date":"2022-12-09","current":-3.484365,"twenty":-8.443246,"median":-2.040115,"eighty":-0.868357,"marketCap":84673542},{"date":"2022-12-16","current":-3.03729,"twenty":-8.443246,"median":-2.05551,"eighty":-0.868357,"marketCap":73809193},{"date":"2022-12-23","current":-3.000295,"twenty":-8.443246,"median":-2.068688,"eighty":-0.868808,"marketCap":72910162},{"date":"2022-12-30","current":-2.753831,"twenty":-8.443246,"median":-2.085832,"eighty":-0.871143,"marketCap":66920842},{"date":"2023-01-06","current":-3.746981,"twenty":-8.443246,"median":-2.103874,"eighty":-0.871143,"marketCap":91055397},{"date":"2023-01-13","current":-4.446251,"twenty":-8.443246,"median":-2.114405,"eighty":-0.871143,"marketCap":108048353},{"date":"2023-01-20","current":-4.202914,"twenty":-8.443246,"median":-2.12012,"eighty":-0.871143,"marketCap":102135007},{"date":"2023-01-27","current":-4.272737,"twenty":-8.443246,"median":-2.152172,"eighty":-0.871143,"marketCap":103831770},{"date":"2023-02-03","current":-4.324843,"twenty":-8.443246,"median":-2.160122,"eighty":-0.871143,"marketCap":105098011},{"date":"2023-02-10","current":-3.782935,"twenty":-8.443246,"median":-2.170132,"eighty":-0.871143,"marketCap":91929103},{"date":"2023-02-17","current":-4.180508,"twenty":-8.443246,"median":-2.171551,"eighty":-0.871143,"marketCap":101590523},{"date":"2023-02-24","current":-3.885585,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":94423598},{"date":"2023-03-03","current":-3.739687,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":90878123},{"date":"2023-03-10","current":-3.51615,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":85445949},{"date":"2023-03-17","current":-3.595351,"twenty":-8.443246,"median":-2.188695,"eighty":-0.871143,"marketCap":87370635},{"date":"2023-03-24","current":-3.27081,"twenty":-8.443246,"median":-2.211554,"eighty":-0.871143,"marketCap":88181030},{"date":"2023-03-31","current":-3.404667,"twenty":-8.430956,"median":-2.238858,"eighty":-0.871736,"marketCap":91789817},{"date":"2023-04-06","current":-3.354412,"twenty":-8.430956,"median":-2.265842,"eighty":-0.871736,"marketCap":90434939},{"date":"2023-04-14","current":-3.474648,"twenty":-8.443246,"median":-2.285844,"eighty":-0.871143,"marketCap":93676516},{"date":"2023-04-21","current":-3.362866,"twenty":-8.443246,"median":-2.361747,"eighty":-0.871143,"marketCap":90662862},{"date":"2023-04-28","current":-2.975854,"twenty":-8.443246,"median":-2.393989,"eighty":-0.871143,"marketCap":80229036},{"date":"2023-05-05","current":-3.179223,"twenty":-8.443246,"median":-2.418171,"eighty":-0.871143,"marketCap":85711860},{"date":"2023-05-12","current":-3.2121,"twenty":-8.443246,"median":-2.472437,"eighty":-0.871143,"marketCap":86598228},{"date":"2023-05-19","current":-3.172389,"twenty":-8.443246,"median":-2.517777,"eighty":-0.871143,"marketCap":90270328},{"date":"2023-05-26","current":-4.297343,"twenty":-8.443246,"median":-2.651908,"eighty":-0.871143,"marketCap":122280903},{"date":"2023-06-02","current":-4.105104,"twenty":-8.443246,"median":-2.695007,"eighty":-0.871143,"marketCap":116810741},{"date":"2023-06-09","current":-4.338283,"twenty":-8.455536,"median":-2.753953,"eighty":-0.87055,"marketCap":123445844},{"date":"2023-06-16","current":-3.99964,"twenty":-8.455536,"median":-2.805078,"eighty":-0.875188,"marketCap":113809750},{"date":"2023-06-23","current":-4.05393,"twenty":-8.467826,"median":-2.839179,"eighty":-0.879396,"marketCap":115354564},{"date":"2023-06-30","current":-5.695971,"twenty":-8.480116,"median":-2.863181,"eighty":-0.884791,"marketCap":162078860},{"date":"2023-07-07","current":-5.473472,"twenty":-8.480116,"median":-2.935338,"eighty":-0.885768,"marketCap":155747655},{"date":"2023-07-14","current":-5.384473,"twenty":-8.480116,"median":-2.980152,"eighty":-0.895581,"marketCap":153215173},{"date":"2023-07-21","current":-5.072974,"twenty":-8.480116,"median":-3.014438,"eighty":-0.910372,"marketCap":144351485},{"date":"2023-07-28","current":-4.627977,"twenty":-8.480116,"median":-3.043022,"eighty":-0.917161,"marketCap":131689074},{"date":"2023-08-04","current":-4.805976,"twenty":-8.480116,"median":-3.123955,"eighty":-0.933492,"marketCap":136754038},{"date":"2023-08-11","current":-4.583477,"twenty":-8.480116,"median":-3.172611,"eighty":-0.944411,"marketCap":130422833},{"date":"2023-08-18","current":-3.510877,"twenty":-8.480116,"median":-3.196041,"eighty":-0.944411,"marketCap":110992860},{"date":"2023-08-25","current":-3.480638,"twenty":-8.480116,"median":-3.230264,"eighty":-0.944411,"marketCap":110036892},{"date":"2023-09-01","current":-3.14284,"twenty":-8.480116,"median":-3.276761,"eighty":-0.944411,"marketCap":99357729},{"date":"2023-09-08","current":-2.958224,"twenty":-8.480116,"median":-3.276761,"eighty":-0.944411,"marketCap":93521296},{"date":"2023-09-15","current":-3.143237,"twenty":-8.480116,"median":-3.287059,"eighty":-0.944411,"marketCap":99370308},{"date":"2023-09-22","current":-3.143237,"twenty":-8.480116,"median":-3.287059,"eighty":-0.955329,"marketCap":99370308},{"date":"2023-09-29","current":-3.00398,"twenty":-8.480116,"median":-3.287483,"eighty":-0.999001,"marketCap":94967826},{"date":"2023-10-06","current":-2.851593,"twenty":-8.480116,"median":-3.287483,"eighty":-1.022217,"marketCap":90150252},{"date":"2023-10-13","current":-2.64589,"twenty":-8.480116,"median":-3.287483,"eighty":-1.080886,"marketCap":83647158},{"date":"2023-10-20","current":-2.625996,"twenty":-8.480116,"median":-3.287483,"eighty":-1.097263,"marketCap":83018232},{"date":"2023-10-27","current":-2.672548,"twenty":-8.481474,"median":-3.302389,"eighty":-1.107436,"marketCap":84489918},{"date":"2023-11-03","current":-2.77719,"twenty":-8.481474,"median":-3.302389,"eighty":-1.108181,"marketCap":87798069},{"date":"2023-11-10","current":-2.637932,"twenty":-8.481474,"median":-3.302389,"eighty":-1.118172,"marketCap":83395587},{"date":"2023-11-17","current":-2.866862,"twenty":-8.481474,"median":-3.302389,"eighty":-1.123293,"marketCap":85521357},{"date":"2023-11-24","current":-3.317947,"twenty":-8.481474,"median":-3.31355,"eighty":-1.135476,"marketCap":98977680},{"date":"2023-12-01","current":-3.121365,"twenty":-8.481474,"median":-3.317947,"eighty":-1.148578,"marketCap":93113449},{"date":"2023-12-08","current":-3.092802,"twenty":-8.481022,"median":-3.31733,"eighty":-1.157037,"marketCap":92261382},{"date":"2023-12-15","current":-3.065919,"twenty":-8.481022,"median":-3.31733,"eighty":-1.172421,"marketCap":91459436},{"date":"2023-12-22","current":-3.087342,"twenty":-8.481022,"median":-3.31733,"eighty":-1.199689,"marketCap":92098487},{"date":"2023-12-29","current":-4.100074,"twenty":-8.481474,"median":-3.320595,"eighty":-1.222251,"marketCap":122309296},{"date":"2024-01-05","current":-3.822423,"twenty":-8.481927,"median":-3.36404,"eighty":-1.247562,"marketCap":114026698},{"date":"2024-01-12","current":-3.79344,"twenty":-8.481927,"median":-3.386925,"eighty":-1.264543,"marketCap":113162100},{"date":"2024-01-19","current":-3.427579,"twenty":-8.48238,"median":-3.404667,"eighty":-1.279259,"marketCap":102248116},{"date":"2024-01-26","current":-3.360372,"twenty":-8.481927,"median":-3.420279,"eighty":-1.305834,"marketCap":100243251},{"date":"2024-02-02","current":-3.52671,"twenty":-8.481927,"median":-3.444381,"eighty":-1.36922,"marketCap":105205292},{"date":"2024-02-09","current":-3.948437,"twenty":-8.481927,"median":-3.461454,"eighty":-1.496,"marketCap":117785820},{"date":"2024-02-16","current":-4.242469,"twenty":-8.481927,"median":-3.475353,"eighty":-1.58074,"marketCap":126557104},{"date":"2024-02-23","current":-4.284474,"twenty":-8.481927,"median":-3.490779,"eighty":-1.630973,"marketCap":127810145},{"date":"2024-03-01","current":-4.103854,"twenty":-8.481474,"median":-3.509376,"eighty":-1.643563,"marketCap":122422070},{"date":"2024-03-08","current":-4.620511,"twenty":-8.481474,"median":-3.526647,"eighty":-1.652044,"marketCap":137834470},{"date":"2024-03-15","current":-5.040558,"twenty":-8.481474,"median":-3.544287,"eighty":-1.672882,"marketCap":150364876},{"date":"2024-03-22","current":-7.056781,"twenty":-8.481474,"median":-3.592657,"eighty":-1.672882,"marketCap":210510827},{"date":"2024-03-28","current":-7.68685,"twenty":-8.481474,"median":-3.649021,"eighty":-1.672882,"marketCap":229306437},{"date":"2024-04-05","current":-7.641157,"twenty":-8.481927,"median":-3.724744,"eighty":-1.671626,"marketCap":263138534},{"date":"2024-04-12","current":-7.369848,"twenty":-8.481927,"median":-3.751671,"eighty":-1.671626,"marketCap":221788193},{"date":"2024-04-19","current":-5.912533,"twenty":-8.481927,"median":-3.788188,"eighty":-1.671626,"marketCap":177931770},{"date":"2024-04-26","current":-6.328909,"twenty":-8.481474,"median":-3.822843,"eighty":-1.672882,"marketCap":190462177},{"date":"2024-05-03","current":-6.328909,"twenty":-8.481474,"median":-3.858489,"eighty":-1.672882,"marketCap":190462177},{"date":"2024-05-10","current":-7.036747,"twenty":-8.481474,"median":-3.885585,"eighty":-1.672882,"marketCap":211763868},{"date":"2024-05-17","current":-6.819219,"twenty":-8.481474,"median":-3.91687,"eighty":-1.672882,"marketCap":202469439},{"date":"2024-05-24","current":-6.183888,"twenty":-8.481474,"median":-3.940818,"eighty":-1.672882,"marketCap":183605827},{"date":"2024-05-31","current":-5.506202,"twenty":-8.481474,"median":-3.97625,"eighty":-1.672882,"marketCap":163484640},{"date":"2024-06-07","current":-5.379136,"twenty":-8.481474,"median":-3.987714,"eighty":-1.672882,"marketCap":159711918},{"date":"2024-06-14","current":-5.209714,"twenty":-8.481927,"median":-4.011197,"eighty":-1.671626,"marketCap":154681621},{"date":"2024-06-21","current":-4.701449,"twenty":-8.48238,"median":-4.074451,"eighty":-1.676651,"marketCap":139590731},{"date":"2024-06-28","current":-4.828516,"twenty":-8.488979,"median":-4.09574,"eighty":-1.683354,"marketCap":143363454},{"date":"2024-07-05","current":-4.955582,"twenty":-8.488979,"median":-4.104479,"eighty":-1.683354,"marketCap":147136176},{"date":"2024-07-12","current":-5.421491,"twenty":-8.488979,"median":-4.121002,"eighty":-1.683354,"marketCap":160969492},{"date":"2024-07-15","current":-5.548557,"twenty":-8.488979,"median":-4.131804,"eighty":-1.683354,"marketCap":164742214},{"date":"2024-08-02","current":-5.463846,"twenty":-8.711157,"median":-4.172692,"eighty":-1.713285,"marketCap":162227066},{"date":"2024-08-09","current":-5.082648,"twenty":-8.711157,"median":-4.200465,"eighty":-1.738217,"marketCap":150908899},{"date":"2024-08-16","current":-6.21264,"twenty":-8.711157,"median":-4.227479,"eighty":-1.751216,"marketCap":160969492},{"date":"2024-08-23","current":-6.649466,"twenty":-8.711157,"median":-4.246162,"eighty":-1.776296,"marketCap":172287659},{"date":"2024-08-30","current":-6.649466,"twenty":-8.711157,"median":-4.273258,"eighty":-1.817246,"marketCap":172287659},{"date":"2024-09-06","current":-6.60093,"twenty":-8.711157,"median":-4.284474,"eighty":-1.839851,"marketCap":171030085},{"date":"2024-09-13","current":-7.280437,"twenty":-8.711157,"median":-4.324843,"eighty":-1.88874,"marketCap":188636124},{"date":"2024-09-20","current":-7.086292,"twenty":-8.711157,"median":-4.370697,"eighty":-1.913185,"marketCap":183605827},{"date":"2024-09-27","current":-6.746538,"twenty":-8.711157,"median":-4.583477,"eighty":-1.929823,"marketCap":174802808},{"date":"2024-10-04","current":-6.843611,"twenty":-8.711157,"median":-4.627977,"eighty":-1.971852,"marketCap":177317956},{"date":"2024-10-11","current":-6.746538,"twenty":-8.711157,"median":-4.729398,"eighty":-2.044171,"marketCap":174802808},{"date":"2024-10-18","current":-7.037756,"twenty":-8.711157,"median":-4.761476,"eighty":-2.084221,"marketCap":182348253},{"date":"2024-10-25","current":-6.843611,"twenty":-8.711157,"median":-4.780081,"eighty":-2.1198,"marketCap":177317956},{"date":"2024-10-31","current":-6.843611,"twenty":-8.711157,"median":-4.828516,"eighty":-2.160122,"marketCap":177317956},{"date":"2024-11-08","current":-7.280437,"twenty":-8.711157,"median":-4.85329,"eighty":-2.209268,"marketCap":188636124},{"date":"2024-11-15","current":-6.404359,"twenty":-8.711157,"median":-4.870871,"eighty":-2.256127,"marketCap":172347717},{"date":"2024-11-22","current":-5.562911,"twenty":-8.711157,"median":-4.894975,"eighty":-2.281272,"marketCap":149703492},{"date":"2024-11-29","current":-6.077129,"twenty":-8.711157,"median":-4.934835,"eighty":-2.312131,"marketCap":163541630},{"date":"2024-12-06","current":-5.609658,"twenty":-8.711157,"median":-4.985169,"eighty":-2.475809,"marketCap":150961504},{"date":"2024-12-13","current":-5.375922,"twenty":-8.711157,"median":-5.040425,"eighty":-2.60998,"marketCap":144671442},{"date":"2024-12-20","current":-4.581221,"twenty":-8.711157,"median":-5.040558,"eighty":-2.633317,"marketCap":123285228},{"date":"2024-12-27","current":-4.955198,"twenty":-8.711157,"median":-5.040558,"eighty":-2.657728,"marketCap":133349329},{"date":"2025-01-03","current":-4.488194,"twenty":-8.711157,"median":-5.040558,"eighty":-2.670479,"marketCap":120781783},{"date":"2025-01-10","current":-4.322709,"twenty":-8.711157,"median":-5.040558,"eighty":-2.691534,"marketCap":116328419},{"date":"2025-01-17","current":-3.957614,"twenty":-8.711157,"median":-5.040558,"eighty":-2.715746,"marketCap":106503341},{"date":"2025-01-24","current":-4.38909,"twenty":-8.711157,"median":-5.040558,"eighty":-2.756011,"marketCap":118114797},{"date":"2025-01-31","current":-4.045031,"twenty":-8.711157,"median":-5.040558,"eighty":-2.780373,"marketCap":108855825},{"date":"2025-02-07","current":-3.763146,"twenty":-8.711157,"median":-5.040558,"eighty":-2.822548,"marketCap":101270009},{"date":"2025-02-14","current":-3.809893,"twenty":-8.711157,"median":-5.040558,"eighty":-2.846579,"marketCap":102528022},{"date":"2025-02-21","current":-3.926293,"twenty":-8.711157,"median":-5.040558,"eighty":-2.862531,"marketCap":105660473},{"date":"2025-02-28","current":-3.482663,"twenty":-8.711157,"median":-5.040558,"eighty":-2.923981,"marketCap":93721934},{"date":"2025-03-07","current":-3.508374,"twenty":-8.711157,"median":-5.040562,"eighty":-2.950266,"marketCap":94413841},{"date":"2025-03-14","current":-3.20405,"twenty":-8.711157,"median":-5.040562,"eighty":-2.980787,"marketCap":86224179},{"date":"2025-03-21","current":-3.344759,"twenty":-8.711157,"median":-5.040562,"eighty":-3.008758,"marketCap":90010797},{"date":"2025-03-28","current":-3.538197,"twenty":-8.711157,"median":-5.040562,"eighty":-3.027033,"marketCap":90238164},{"date":"2025-04-04","current":-3.254067,"twenty":-8.711157,"median":-5.040562,"eighty":-3.056151,"marketCap":82991727},{"date":"2025-04-11","current":-2.986651,"twenty":-8.711157,"median":-5.040558,"eighty":-3.060228,"marketCap":76171551},{"date":"2025-04-17","current":-3.064141,"twenty":-8.711157,"median":-5.040558,"eighty":-3.067271,"marketCap":78147852},{"date":"2025-04-25","current":-3.710396,"twenty":-8.711157,"median":-5.040562,"eighty":-3.087342,"marketCap":94629944},{"date":"2025-05-02","current":-4.269539,"twenty":-8.711157,"median":-5.040562,"eighty":-3.101923,"marketCap":108890313},{"date":"2025-05-09","current":-4.101391,"twenty":-8.711157,"median":-5.040562,"eighty":-3.137555,"marketCap":104601869},{"date":"2025-05-16","current":-4.832598,"twenty":-8.711157,"median":-5.042039,"eighty":-3.145675,"marketCap":127309955},{"date":"2025-05-23","current":-4.265297,"twenty":-8.711157,"median":-5.042039,"eighty":-3.158264,"marketCap":112364986},{"date":"2025-05-30","current":-3.728887,"twenty":-8.711157,"median":-5.042039,"eighty":-3.172478,"marketCap":98233788},{"date":"2025-06-06","current":-4.215775,"twenty":-8.711157,"median":-5.042039,"eighty":-3.190566,"marketCap":111060369},{"date":"2025-06-13","current":-4.230484,"twenty":-8.711157,"median":-5.042039,"eighty":-3.19945,"marketCap":111447879},{"date":"2025-06-20","current":-3.938253,"twenty":-8.711157,"median":-5.043513,"eighty":-3.221964,"marketCap":103749347},{"date":"2025-06-27","current":-4.302071,"twenty":-8.711157,"median":-5.043513,"eighty":-3.242254,"marketCap":113333761},{"date":"2025-07-03","current":-4.16331,"twenty":-8.711157,"median":-5.043513,"eighty":-3.267121,"marketCap":109678250},{"date":"2025-07-11","current":-4.353555,"twenty":-8.711157,"median":-5.043513,"eighty":-3.282712,"marketCap":114690046},{"date":"2025-07-18","current":-4.263336,"twenty":-8.711157,"median":-5.043513,"eighty":-3.302389,"marketCap":112313318},{"date":"2025-07-25","current":-4.226071,"twenty":-8.711157,"median":-5.043513,"eighty":-3.320595,"marketCap":111331626},{"date":"2025-08-01","current":-4.089272,"twenty":-8.711157,"median":-5.043513,"eighty":-3.360372,"marketCap":107727783},{"date":"2025-08-08","current":-3.786744,"twenty":-8.711157,"median":-5.043513,"eighty":-3.382122,"marketCap":99757994},{"date":"2025-08-15","current":-3.508832,"twenty":-8.711157,"median":-5.043513,"eighty":-3.388701,"marketCap":100766627},{"date":"2025-08-22","current":-3.346457,"twenty":-8.711157,"median":-5.043513,"eighty":-3.398176,"marketCap":96103539},{"date":"2025-08-29","current":-3.391886,"twenty":-8.711157,"median":-5.043513,"eighty":-3.404667,"marketCap":97408170},{"date":"2025-09-05","current":-3.4688,"twenty":-8.738689,"median":-5.046907,"eighty":-3.422514,"marketCap":99617002},{"date":"2025-09-12","current":-3.702692,"twenty":-8.711157,"median":-5.043513,"eighty":-3.43178,"marketCap":106333916},{"date":"2025-09-19","current":-3.957725,"twenty":-8.711157,"median":-5.043513,"eighty":-3.444381,"marketCap":113657935},{"date":"2025-09-26","current":-3.673456,"twenty":-8.711157,"median":-5.043513,"eighty":-3.457823,"marketCap":105494301},{"date":"2025-10-03","current":-4.138091,"twenty":-8.711157,"median":-5.043513,"eighty":-3.465085,"marketCap":118837710},{"date":"2025-10-10","current":-5.307552,"twenty":-8.711157,"median":-5.0503,"eighty":-3.474716,"marketCap":152422280},{"date":"2025-10-17","current":-4.632863,"twenty":-8.711157,"median":-5.0503,"eighty":-3.477591,"marketCap":133046566},{"date":"2025-10-24","current":-4.117401,"twenty":-8.711157,"median":-5.0503,"eighty":-3.487242,"marketCap":118243521},{"date":"2025-10-31","current":-3.958174,"twenty":-8.711157,"median":-5.0503,"eighty":-3.505307,"marketCap":113670853},{"date":"2025-11-07","current":-3.66356,"twenty":-8.711157,"median":-5.0503,"eighty":-3.509376,"marketCap":105210124},{"date":"2025-11-14","current":-3.610485,"twenty":-8.711157,"median":-5.0503,"eighty":-3.5238,"marketCap":103685902},{"date":"2025-11-21","current":-3.218585,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52567,"marketCap":97136910},{"date":"2025-11-28","current":-3.327726,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52567,"marketCap":100430782},{"date":"2025-12-05","current":-3.250686,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52567,"marketCap":98105696},{"date":"2025-12-12","current":-3.872575,"twenty":-8.711157,"median":-5.0503,"eighty":-3.526548,"marketCap":116874304},{"date":"2025-12-19","current":-3.014,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52671,"marketCap":90962516}],"updateTime":1766234779756},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATOS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575292072","title":"Atossa Therapeutics - Heather Rees Steps Down as CFO, Assists Transition Until Nov 15 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575292072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575292072?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:51","pubTimestamp":1760442677,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VU308:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2575292021","title":"Atossa Therapeutics Appoints Mark Daniel as Chief Financial Officer to Lead Commercial Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2575292021","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575292021?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:50","pubTimestamp":1760442656,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. has announced the appointment of Mark Daniel as Chief Financial Officer. Daniel brings over 25 years of experience in life sciences finance and will lead Atossa's finance, systems, and capital strategy as the company prepares for commercial operations with its breast cancer treatment candidate, -endoxifen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL3QtJ5q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2575405973","title":"Atossa Therapeutics Granted Israeli Patent for High-Purity Z-Endoxifen Formulations","url":"https://stock-news.laohu8.com/highlight/detail?id=2575405973","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575405973?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:00","pubTimestamp":1760356851,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. announced the issuance of a new patent in Israel for its Z-endoxifen program. The granted patent, No. 304863, covers high-purity Z-endoxifen enteric formulations, performance characteristics, and manufacturing methods. The protection includes oral, delayed-release dosage forms containing at least 90% by weight Z-endoxifen, specific impurity limits, defined release characteristics, various dose strengths, and pharmacokinetic performance targets. The company also received confirmation of the patent's renewal status from the Israel Patent Office.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on October 13, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDLLRTqV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2573729156","title":"BRIEF-Atossa Therapeutics Streamlines Evangeline Breast Cancer Clinical Trial To Prioritize For 2026 NDA-Enabling Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2573729156","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573729156?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:24","pubTimestamp":1759753450,"startTime":"0","endTime":"0","summary":"BRIEF-Atossa Therapeutics Streamlines Evangeline Breast Cancer Clinical Trial To Prioritize For 2026 NDA-Enabling ActivitiesOct 6 (Reuters) - Atossa Therapeutics Inc ATOS.O:ATOSSA THERAPEUTICS STREAML","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA73NFWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":1},{"id":"2573767442","title":"Atossa Therapeutics - No Change to Patient Safety Data Collection or Data Safety Monitoring Committee Oversight by This Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2573767442","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573767442?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:00","pubTimestamp":1759752035,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA73NFWC:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2573674927","title":"Atossa Therapeutics Streamlines Evangeline Breast Cancer Clinical Trial to Prioritize for 2026 Nda-Enabling Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2573674927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573674927?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:00","pubTimestamp":1759752035,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA73NFWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2573674426","title":"Atossa Therapeutics Inc - Focuses on Nda-Enabling Activities for Investigational (Z)-Endoxifen in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2573674426","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573674426?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:00","pubTimestamp":1759752035,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA73NFWC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2573674424","title":"Atossa Therapeutics Inc - Evangeline Study Patient Total Reduced to 40-65","url":"https://stock-news.laohu8.com/highlight/detail?id=2573674424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573674424?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:00","pubTimestamp":1759752035,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA73NFWC:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2573674192","title":"Atossa Therapeutics Inc - Changes Expected to Reduce Study Costs and Accelerate Readouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2573674192","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573674192?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:00","pubTimestamp":1759752035,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA73NFWC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2572397325","title":"Atossa Therapeutics Appoints Janet R. Rea as Senior Vice President of R&D to Accelerate (Z)-Endoxifen Toward Regulatory Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2572397325","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572397325?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:31","pubTimestamp":1759321873,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Appoints Janet R. Rea as Senior Vice President of R&D to Accelerate -Endoxifen Toward Regulatory Milestones. Atossa Therapeutics Inc. has appointed Janet R. Rea, MSPH, as Senior Vice President, R&D. Rea will oversee late-stage development and help advance the company's lead product candidate, -endoxifen, toward commercialization. She brings over 20 years of experience in clinical and regulatory development to her new role.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on October 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nNDLbvLJ6Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2570583087","title":"Atossa Therapeutics Inc. Releases Updated Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2570583087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570583087?lang=en_us&edition=fundamental","pubTime":"2025-09-27 05:13","pubTimestamp":1758921201,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. has released an updated corporate presentation, as disclosed in a recent Form 8-K filing dated September 26, 2025. The document provides the latest information about the company's activities and outlook. However, the provided announcement does not include a URL to access the document.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nNDL5RWWKJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2565681420","title":"BRIEF-Atossa Unveils Regulatory Strategy to Fast-Track (Z)-Endoxifen for Breast Cancer Risk Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2565681420","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565681420?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:48","pubTimestamp":1757335734,"startTime":"0","endTime":"0","summary":"BRIEF-Atossa Unveils Regulatory Strategy to Fast-Track (Z)-Endoxifen for Breast Cancer Risk ReductionSept 8 (Reuters) - Atossa Therapeutics Inc ATOS.O:ATOSSA THERAPEUTICS ANNOUNCES REGULATORY STRATEGY","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA4KWSQQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2565968187","title":"Atossa Therapeutics Inc. Requests Type C FDA Meeting to Expedite Development of Low-Dose (Z)-Endoxifen for Breast Cancer Risk Reduction; Update Expected by Year-End 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2565968187","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565968187?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:31","pubTimestamp":1757334705,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. Requests Type C FDA Meeting to Expedite Development of Low-Dose -Endoxifen for Breast Cancer Risk Reduction; Update Expected by Year-End 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on September 08, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nNDL2zm8sM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2565681364","title":"Atossa Therapeutics Inc - Requests Type C Meeting With FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2565681364","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565681364?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:30","pubTimestamp":1757334608,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA4KWSQQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2565681334","title":"Atossa Therapeutics Inc - Expects Meeting Outcome Update by Year-End 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2565681334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565681334?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:30","pubTimestamp":1757334608,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA4KWSQQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2565168183","title":"Atossa Therapeutics Announces Regulatory Strategy Aimed at Accelerating Development of Low-Dose (Z)-Endoxifen for Breast Cancer Risk Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2565168183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565168183?lang=en_us&edition=fundamental","pubTime":"2025-09-08 20:30","pubTimestamp":1757334608,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nTUA4KWSQQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2562032636","title":"Atossa Therapeutics Announces New Clinical Study Progress and Upcoming Milestones for Breast Cancer Treatment at H.C. Wainwright Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2562032636","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562032636?lang=en_us&edition=fundamental","pubTime":"2025-08-28 20:30","pubTimestamp":1756384239,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Announces New Clinical Study Progress and Upcoming Milestones for Breast Cancer Treatment at H.C. Wainwright Conference. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on August 28, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL6fN96Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2561267415","title":"Atossa Therapeutics Receives Nasdaq Notice for Non-Compliance with Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2561267415","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561267415?lang=en_us&edition=fundamental","pubTime":"2025-08-22 04:06","pubTimestamp":1755806772,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. announced that it has received a notice from The Nasdaq Stock Market LLC regarding non-compliance with the minimum bid price requirement for continued listing. The company's common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days, as required by Nasdaq Listing Rule 5550. Initially, the compliance period ended on August 20, 2025, but Atossa has successfully requested an extension, now having until February 17, 2026, to regain compliance. The company is actively monitoring its stock price and is considering options to meet the listing requirement, including a potential reverse stock split if necessary. The notice currently does not affect the trading or listing of Atossa's common stock on Nasdaq.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL3vgvZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2560111105","title":"Atossa Therapeutics Announces Pivotal Phase 2 Study of (Z)-Endoxifen in Metastatic Breast Cancer with PSI as Contract Research Organization","url":"https://stock-news.laohu8.com/highlight/detail?id=2560111105","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560111105?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:31","pubTimestamp":1755693108,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Announces Pivotal Phase 2 Study of -Endoxifen in Metastatic Breast Cancer with PSI as Contract Research Organization. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on August 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDLbzqfgX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2560907105","title":"Atossa Therapeutics Selects PSI as Contract Research Organization for Pivotal Dose-Ranging Study of (Z)-Endoxifen in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2560907105","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560907105?lang=en_us&edition=fundamental","pubTime":"2025-08-20 20:30","pubTimestamp":1755693003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nTUA3SFYLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}]}}